Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression

Abstract

Antidepressant augmentation with VPA provided substantial clinical improvement and maintenance over a relatively long-term period in a subgroup of patients with severe TRD. VPA thus deserves further exploration in large double-blind clinical trials.